转录组
微流控
单细胞分析
计算机科学
细胞
计算生物学
追踪
纳米技术
生物
材料科学
基因
遗传学
基因表达
操作系统
作者
Yang Liu,Shiyu Wang,Menghua Lyu,Run Xie,Weijin Guo,Ying He,Xuyang Shi,Yang Wang,Jingyu Qi,Qianqian Zhu,Hui Zhang,Tao Luo,Huaying Chen,Yonggang Zhu,Xuan Dong,Zida Li,Ying Gu,Feng Mu,Longqi Liu,Xun Xu
出处
期刊:Bioengineering
[Multidisciplinary Digital Publishing Institute]
日期:2022-11-10
卷期号:9 (11): 674-674
被引量:15
标识
DOI:10.3390/bioengineering9110674
摘要
The rapid promotion of single-cell omics in various fields has begun to help solve many problems encountered in research, including precision medicine, prenatal diagnosis, and embryo development. Meanwhile, single-cell techniques are also constantly updated with increasing demand. For some specific target cells, the workflow from droplet screening to single-cell sequencing is a preferred option and should reduce the impact of operation steps, such as demulsification and cell recovery. We developed an all-in-droplet method integrating cell encapsulation, target sorting, droplet picoinjection, and single-cell transcriptome profiling on chips to achieve labor-saving monitoring of TCR-T cells. As a proof of concept, in this research, TCR-T cells were encapsulated, sorted, and performed single-cell transcriptome sequencing (scRNA-seq) by injecting reagents into droplets. It avoided the tedious operation of droplet breakage and re-encapsulation between droplet sorting and scRNA-seq. Moreover, convenient device operation will accelerate the progress of chip marketization. The strategy achieved an excellent recovery performance of single-cell transcriptome with a median gene number over 4000 and a cross-contamination rate of 8.2 ± 2%. Furthermore, this strategy allows us to develop a device with high integrability to monitor infused TCR-T cells, which will promote the development of adoptive T cell immunotherapy and their clinical application.
科研通智能强力驱动
Strongly Powered by AbleSci AI